Dynamics of immunoglobulins production in infected children born to HIV-1 infected mothers: Effect of zidovudine;Dinámica de producción de inmunoglobulinas en niños no infectados nacidos de madres infectadas por el VIH-1: Efecto de la zidovudina

Medicina Clinica

Volumn 112, Issue 15, 1999, Pages 568-571

  Resino, Salvador ^a   Gurbindo, María Dolores ^a   Bellón, José María ^a   Jiménez, José Luis ^a   León, J Antonio ^b   Navarro, Joaquín ^a   Muñoz Fernández, María Angeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CHILD; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; NEPHELOMETRY; VERTICAL TRANSMISSION; ANTIBODY PRODUCTION; BIOSYNTHESIS; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; INFANT; INFANT WELFARE; MATERNAL WELFARE; NEWBORN; PREGNANCY; RETROSPECTIVE STUDY;

ANTI-HIV AGENTS; ANTIBODY FORMATION; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT WELFARE; INFANT, NEWBORN; MATERNAL WELFARE; PREGNANCY; RETROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 0033136856     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Connor EM, Sperling RS, Gelber R, Kiseler P, Scott G, O'Sullivan MJ et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group protocol 076 study group. N Engl J Med 1994; 331: 1.173-1.180.
2. Peckham C, Gibb D. Mother-to-child transmission of human immunodeficiency virus. N Engl J Med 1995; 333: 298-302.
3. Bates Egan I. Factores maternos y de la transmisión vertical. Allerg Immunopath 1998; 26: 120-121.
4. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL et al. The toxicity of azidithymidine (AZT) in the treatment of patient with AIDS and AIDS-related complex. N Engl J Med 1987; 317: 192-197.
5. Boucher FD, Modlin JF, Weller S, Ruff A, Mirocknick M, Pelton S et al. Phase Y evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993; 122: 137-144.
6. Liebes L, Mendoza S, Wilson D, Dancis J. Transfer of zidovudine (AZT) by human placenta. J Infect Dis 1990; 161: 203-207.
7. Shah MM, Li Y, Chistensen RD. Effects of perinatal zidovudine on hematopoiesis: a comparision of effects on progenitors from human fetuses versus mothers. AIDS 1996; 10: 1.239-1.247.
8. O'Sullivan MJ, Boyer PJJ, Scott GB, Parks WP, Weller S, Blum MR et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: group study (protocol 082). Am J Obstet Gynecol 1993; 168: 1.510-1.516.
9. Sperling RS, Roboz J, Dische R, Silides D, Holzman I. Jew E et al. Zidovudine pharmacokinetics during pregnancy. Am J Perinatol 1992; 9: 247-249.
10. a ed.) St. Louis: Mosby, 1996; 2: 139.
11. Muñoz-Fernández MA, Obregón E, Navarro J, Borner C, Gurbindo D, Sampelayo TH et al. Relationship among virological, immunological and clinical parameters in infants with vertically acquired human immunodeficiency virus (HIV-1) infection. Pediatr Res 1996; 40: 597-602.
12. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230-235.
13. White A, Eldridge R, Andrews E, and the Retroviral Pregnancy Registry Advisory Committee. Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry. Acta Paediatr 1997; 421 (Supl): 86-88.
14. Englun JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med 1997; 336: 1.704-1.712.
15. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M et al. Combination. Treatment with zidovudine, didanosine and nevirepine in infants with human immunodeficiency virus type 1 infection. N Engl J Med 1997; 336: 1.343-1.349.